AngioDynamics, Inc. (NASDAQ:ANGO) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
AngioDynamics, Inc. (NASDAQ:ANGO) Held Back By Insufficient Growth Even After Shares Climb 26%
When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?
AngioDynamics Price Target Cut to $13.00/Share From $18.00 by Canaccord Genuity
AngioDynamics Is Maintained at Buy by Canaccord Genuity
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $13
AngioDynamics (ANGO) Q4 Earnings Top Estimates, Gross Margin Down
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Argenx Se (ARGX) and AngioDynamics (ANGO)
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
Express News | HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target
AngioDynamics Analyst Ratings
Q4 2024 AngioDynamics Inc Earnings Call
Express News | AngioDynamics Inc : Canaccord Genuity Cuts Target Price to $13 From $18
Silo SILO License Agreement; AngioDynamics ANGO Earnings
Sector Update: Health Care Stocks Gain in Afternoon Trading
Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
AngioDynamics Shares Rise After Fiscal Q4 Results, Share Repurchase Program
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript